NL6614961A - - Google Patents
Info
- Publication number
- NL6614961A NL6614961A NL6614961A NL6614961A NL6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH506468A CH478818A (de) | 1965-10-22 | 1965-10-22 | Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen |
| CH506368A CH478817A (de) | 1965-10-22 | 1965-10-22 | Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen |
| CH506568A CH478819A (de) | 1965-10-22 | 1965-10-22 | Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen |
| CH1463065A CH478816A (de) | 1965-10-22 | 1965-10-22 | Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen |
| CH1751468A CH499528A (de) | 1965-10-22 | 1965-10-22 | Verfahren zur Herstellung neuer Pyrimidine |
| CH1133066 | 1966-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6614961A true NL6614961A (en:Method) | 1967-04-24 |
Family
ID=27543760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6614961A NL6614961A (en:Method) | 1965-10-22 | 1966-10-21 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3503963A (en:Method) |
| BE (1) | BE688660A (en:Method) |
| BR (1) | BR6683919D0 (en:Method) |
| CH (5) | CH499528A (en:Method) |
| DE (1) | DE1670392A1 (en:Method) |
| FR (3) | FR1500479A (en:Method) |
| GB (1) | GB1135259A (en:Method) |
| IL (1) | IL26473A (en:Method) |
| NL (1) | NL6614961A (en:Method) |
| SE (1) | SE345273B (en:Method) |
| SU (2) | SU436494A3 (en:Method) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7470699B2 (en) | 2003-07-11 | 2008-12-30 | Arena Pharmaceuticals, Inc. | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US7812159B2 (en) | 2005-01-10 | 2010-10-12 | Arena Pharamaceuticals, Inc. | Processes for preparing aromatic ethers |
| US8293751B2 (en) | 2003-01-14 | 2012-10-23 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| US8362248B2 (en) | 2005-01-10 | 2013-01-29 | Arena Pharmaceuticals, Inc. | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| US10894787B2 (en) | 2010-09-22 | 2021-01-19 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| US11534424B2 (en) | 2017-02-16 | 2022-12-27 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| US11884626B2 (en) | 2015-06-22 | 2024-01-30 | Arena Pharmaceuticals, Inc. | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders |
| US12156866B2 (en) | 2018-06-06 | 2024-12-03 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH485753A (de) * | 1966-07-28 | 1970-02-15 | Ciba Geigy | Verfahren zur Herstellung neuer Aminopyrimidine |
| DE602004017703D1 (de) * | 2003-02-24 | 2008-12-24 | Arena Pharm Inc | Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus |
| MXPA06014129A (es) * | 2004-06-04 | 2007-03-07 | Arena Pharm Inc | Derivados de arilo y heteroarilo sustituidos como moduladores del metabolismo y profilaxis y tratamiento de trastornos relacionados con los mismos. |
| GT200500284A (es) * | 2004-10-15 | 2006-03-27 | Aventis Pharma Inc | Pirimidinas como antagonistas del receptor de prostaglandina d2 |
| ES2326391T3 (es) * | 2005-09-16 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo. |
| TW200811140A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| TW200811147A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| JP5856980B2 (ja) | 2010-01-27 | 2016-02-10 | アリーナ ファーマシューティカルズ， インコーポレイテッド | （Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB944443A (en:Method) * | 1959-09-25 | 1900-01-01 |
-
1965
- 1965-10-22 CH CH1751468A patent/CH499528A/de not_active IP Right Cessation
- 1965-10-22 CH CH506468A patent/CH478818A/de not_active IP Right Cessation
- 1965-10-22 CH CH506568A patent/CH478819A/de not_active IP Right Cessation
- 1965-10-22 CH CH1463065A patent/CH478816A/de not_active IP Right Cessation
- 1965-10-22 CH CH506368A patent/CH478817A/de not_active IP Right Cessation
-
1966
- 1966-09-07 IL IL26473A patent/IL26473A/en unknown
- 1966-10-07 SU SU1106159A patent/SU436494A3/ru active
- 1966-10-07 SU SU1335465A patent/SU427513A3/ru active
- 1966-10-14 FR FR80113A patent/FR1500479A/fr not_active Expired
- 1966-10-14 DE DE19661670392 patent/DE1670392A1/de active Pending
- 1966-10-17 GB GB46245/66A patent/GB1135259A/en not_active Expired
- 1966-10-21 SE SE14418/66A patent/SE345273B/xx unknown
- 1966-10-21 BE BE688660D patent/BE688660A/xx unknown
- 1966-10-21 NL NL6614961A patent/NL6614961A/xx unknown
- 1966-10-21 BR BR183919/66A patent/BR6683919D0/pt unknown
- 1966-11-30 US US597870A patent/US3503963A/en not_active Expired - Lifetime
-
1967
- 1967-01-05 FR FR90061A patent/FR6083M/fr not_active Expired
- 1967-01-05 FR FR90062A patent/FR6084M/fr not_active Expired
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293751B2 (en) | 2003-01-14 | 2012-10-23 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| US8933083B2 (en) | 2003-01-14 | 2015-01-13 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| US7470699B2 (en) | 2003-07-11 | 2008-12-30 | Arena Pharmaceuticals, Inc. | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US7838525B2 (en) | 2003-07-11 | 2010-11-23 | Arena Pharmaceuticals, Inc. | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US8546429B2 (en) | 2003-07-11 | 2013-10-01 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US7812159B2 (en) | 2005-01-10 | 2010-10-12 | Arena Pharamaceuticals, Inc. | Processes for preparing aromatic ethers |
| US8362248B2 (en) | 2005-01-10 | 2013-01-29 | Arena Pharmaceuticals, Inc. | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| US10894787B2 (en) | 2010-09-22 | 2021-01-19 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| US11884626B2 (en) | 2015-06-22 | 2024-01-30 | Arena Pharmaceuticals, Inc. | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders |
| US11534424B2 (en) | 2017-02-16 | 2022-12-27 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| US12156866B2 (en) | 2018-06-06 | 2024-12-03 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
Also Published As
| Publication number | Publication date |
|---|---|
| BR6683919D0 (pt) | 1973-12-04 |
| BE688660A (en:Method) | 1967-04-21 |
| CH478819A (de) | 1969-09-30 |
| SU436494A3 (ru) | 1974-07-15 |
| CH478817A (de) | 1969-09-30 |
| FR6084M (en:Method) | 1968-06-04 |
| DE1670392A1 (de) | 1970-07-16 |
| CH499528A (de) | 1970-11-30 |
| GB1135259A (en) | 1968-12-04 |
| CH478816A (de) | 1969-09-30 |
| CH478818A (de) | 1969-09-30 |
| US3503963A (en) | 1970-03-31 |
| SU427513A3 (ru) | 1974-05-05 |
| FR6083M (en:Method) | 1968-06-04 |
| IL26473A (en) | 1971-08-25 |
| FR1500479A (fr) | 1967-11-03 |
| SE345273B (en:Method) | 1972-05-23 |